You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Baseline characteristics of smear-negative presumptive TB patients, overall and by whether they had received an Xpert® MTB/RIF

From: Treatment decisions and mortality in HIV-positive presumptive smear-negative TB in the Xpert® MTB/RIF era: a cohort study

Characteristic   No XP XP Total P-value
Total (n [%])   236 (57.4) 175 (42.6) 411 (100)  
Age (mean [SD])   38 (9) 40 (11) 39 (10) 0.10
Female sex (n [%])   133 (56.4) 99 (56.6) 232 (56.4) 0.97
CD4 count (median [IQR])*   274 (147, 422) 275 (179, 478) 275 (162, 426) 0.73
ART at TB treatment initiation (n [%])   116 (49.2) 89 (50.9) 205 (49.9) 0.73
Prior TB treatment (n [%])   34 (14.4) 29 (16.6) 63 (15.3) 0.55
Symptomatology at presentation (n [%]) Cough 228 (96.6) 173 (98.9) 401 (97.6) 0.14
Fever 169 (71.6) 124 (70.9) 293 (71.3) 0.87
Night sweats 112 (47.5) 88 (50.3) 200 (48.7) 0.57
Weight loss 80 (33.9) 63 (36) 143 (34.8) 0.66
Anorexia 113 (47.9) 84 (48) 197 (47.9) 0.98
Chest pain 64 (27.1) 57 (32.6) 121 (29.4) 0.23
  1. IQR interquartile range, n number, SD standard deviation, TB tuberculosis, XP Xpert® MTB/RIF
  2. *On 200, 152 and 352 patients, respectively